News

SKNV’s Fran Malkin Co-Authors “Flip the Script” with Best-Selling Author and Negotiation Icon Chris Voss

Launching today July 17, 2025 and available on Amazon FORT LAUDERDALE, Fla., July 17, 2025 /PRNewswire/ -- SKNV, a leader…

6 months ago

Kyruus Health Expands Reach to Integrate with Bing and Other AI Experiences Consumers Use to Find Care

BOSTON, July 17, 2025 /PRNewswire/ -- Building on the successful launch of Reach in October 2024, Kyruus Health, the leading…

6 months ago

Philips Launches ECG AI Marketplace to Enhance Early Cardiac Diagnosis

Philips Cardiac Workstation July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution available through Philips’ ECG ecosystem…

6 months ago

Adventure Awaits: Make-A-Wish® Central and Northern Florida Makes Jeremy’s Dream Come True with a Thrilling Mexican Sport Fishing Adventure

Family to Embark on an Unforgettable Trip, Courtesy of Stan and Naomi LoomisORLANDO, Fla., July 17, 2025 (GLOBE NEWSWIRE) --…

6 months ago

Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a…

6 months ago

OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain

LONDON and NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which…

6 months ago

RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD

Acquisition contributes iCAD's commercial, technology, and regulatory capabilitiesThe acquisition positions DeepHealth with an industry-leading suite of AI-powered breast cancer image interpretation and…

6 months ago

Tria Federal Expands VA Partnership with $174M Software Engineering & Development Award

VA Contract Announcement Tria Federal has received a $174 million contract award to provide expanded software engineering and development services…

6 months ago

Actuate Therapeutics Advances Clinical Program in Ewing Sarcoma After Positive Phase 1 Trial Demonstrates Complete and Partial Responses in Difficult-to-Treat Pediatric Sarcomas

- Announces Completion of Phase 1 Study of Elraglusib in Pediatric Patients - Prolonged and Durable Complete Responses (CRs) Observed…

6 months ago